These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 29287685)

  • 1. Medicinal plants and bioactive natural compounds in the treatment of non-alcoholic fatty liver disease: A clinical review.
    Bagherniya M; Nobili V; Blesso CN; Sahebkar A
    Pharmacol Res; 2018 Apr; 130():213-240. PubMed ID: 29287685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phytotherapy as Multi-Hit Therapy to Confront the Multiple Pathophysiology in Non-Alcoholic Fatty Liver Disease: A Systematic Review of Experimental Interventions.
    Ore A; Akinloye OA
    Medicina (Kaunas); 2021 Aug; 57(8):. PubMed ID: 34441028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herbal medicines and nonalcoholic fatty liver disease.
    Yao H; Qiao YJ; Zhao YL; Tao XF; Xu LN; Yin LH; Qi Y; Peng JY
    World J Gastroenterol; 2016 Aug; 22(30):6890-905. PubMed ID: 27570425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural Active Compounds from Plant Food and Chinese Herbal Medicine for Nonalcoholic Fatty Liver Disease.
    Liu Q; Zhu L; Cheng C; Hu YY; Feng Q
    Curr Pharm Des; 2017; 23(34):5136-5162. PubMed ID: 28925892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic Potential of Herbal Medicine against Non-alcoholic Fatty Liver Disease.
    Pourali G; Hosseini ZS; Maftooh M; Nazari E; Khazaei M; Nassiri M; Hassanian SM; Ghayour-Mobarhan M; Ferns GA; Kiani MA; Avan A
    Curr Drug Targets; 2023; 24(4):300-319. PubMed ID: 36642873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flavonoids and Related Compounds in Non-Alcoholic Fatty Liver Disease Therapy.
    Pisonero-Vaquero S; González-Gallego J; Sánchez-Campos S; García-Mediavilla MV
    Curr Med Chem; 2015; 22(25):2991-3012. PubMed ID: 26242257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement.
    Athyros VG; Alexandrides TK; Bilianou H; Cholongitas E; Doumas M; Ganotakis ES; Goudevenos J; Elisaf MS; Germanidis G; Giouleme O; Karagiannis A; Karvounis C; Katsiki N; Kotsis V; Kountouras J; Liberopoulos E; Pitsavos C; Polyzos S; Rallidis LS; Richter D; Tsapas AG; Tselepis AD; Tsioufis K; Tziomalos K; Tzotzas T; Vasiliadis TG; Vlachopoulos C; Mikhailidis DP; Mantzoros C
    Metabolism; 2017 Jun; 71():17-32. PubMed ID: 28521870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Combined Intervention with Germinated Vigna radiata and Aerobic Interval Training Protocol Is an Effective Strategy for the Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD) and Other Alterations Related to the Metabolic Syndrome in Zucker Rats.
    Kapravelou G; Martínez R; Nebot E; López-Jurado M; Aranda P; Arrebola F; Cantarero S; Galisteo M; Porres JM
    Nutrients; 2017 Jul; 9(7):. PubMed ID: 28753963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relevant Aspects of Nutritional and Dietary Interventions in Non-Alcoholic Fatty Liver Disease.
    Hernandez-Rodas MC; Valenzuela R; Videla LA
    Int J Mol Sci; 2015 Oct; 16(10):25168-98. PubMed ID: 26512643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herbal medicines for fatty liver diseases.
    Liu ZL; Xie LZ; Zhu J; Li GQ; Grant SJ; Liu JP
    Cochrane Database Syst Rev; 2013 Aug; (8):CD009059. PubMed ID: 23975682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural antioxidants for non-alcoholic fatty liver disease: molecular targets and clinical perspectives.
    Salomone F; Godos J; Zelber-Sagi S
    Liver Int; 2016 Jan; 36(1):5-20. PubMed ID: 26436447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential of flavonoids in the treatment of non-alcoholic fatty liver disease.
    Van De Wier B; Koek GH; Bast A; Haenen GR
    Crit Rev Food Sci Nutr; 2017 Mar; 57(4):834-855. PubMed ID: 25897647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicinal Plants and Phytochemicals Regulating Insulin Resistance and Glucose Homeostasis in Type 2 Diabetic Patients: A Clinical Review.
    Mahdavi A; Bagherniya M; Mirenayat MS; Atkin SL; Sahebkar A
    Adv Exp Med Biol; 2021; 1308():161-183. PubMed ID: 33861444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study.
    Faghihzadeh F; Adibi P; Hekmatdoost A
    Br J Nutr; 2015 Sep; 114(5):796-803. PubMed ID: 26234526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Green tea polyphenol epigallocatechin-3-gallate ameliorates insulin resistance in non-alcoholic fatty liver disease mice.
    Gan L; Meng ZJ; Xiong RB; Guo JQ; Lu XC; Zheng ZW; Deng YP; Luo BD; Zou F; Li H
    Acta Pharmacol Sin; 2015 May; 36(5):597-605. PubMed ID: 25891086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Takahashi Y; Sugimoto K; Inui H; Fukusato T
    World J Gastroenterol; 2015 Apr; 21(13):3777-85. PubMed ID: 25852263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chinese herbal medicines: The modulator of nonalcoholic fatty liver disease targeting oxidative stress.
    Gong P; Long H; Guo Y; Wang Z; Yao W; Wang J; Yang W; Li N; Xie J; Chen F
    J Ethnopharmacol; 2024 Jan; 318(Pt B):116927. PubMed ID: 37532073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
    Eslami L; Merat S; Malekzadeh R; Nasseri-Moghaddam S; Aramin H
    Cochrane Database Syst Rev; 2013 Dec; (12):CD008623. PubMed ID: 24374462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NAFLD: a multisystem disease.
    Byrne CD; Targher G
    J Hepatol; 2015 Apr; 62(1 Suppl):S47-64. PubMed ID: 25920090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omega-3 fatty acids: Mechanisms of benefit and therapeutic effects in pediatric and adult NAFLD.
    Nobili V; Alisi A; Musso G; Scorletti E; Calder PC; Byrne CD
    Crit Rev Clin Lab Sci; 2016; 53(2):106-20. PubMed ID: 26463349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.